1. Bad bugs, no drugs: as antibiotic R&D stagnates... a public health crisis brews (Infectious Diseases Society of America, Alexandria, Virginia, 2004).
2. Utility Examination Guidelines, 66 Fed. Reg. 1092
http://www.uspto.gov/web/officer/com/sol/notices/utilexmguide.pdf
(2001).
3. Tufts Center for the Study of Drug Development pegs cost of a new prescription medicine at $802 million.
http://csdd.tufts.edu/NewsEvents/RecentNews.asp?newsid=6
(2001).
4. Fermini, B. & Fossa, A.A. Nat. Rev. Drug Discov. 2, 439–447 (2003).
5. Harris, G. Approval of antibiotic worried safety officials. New York Times (19 July 2006).